<DOC>
	<DOCNO>NCT00986050</DOCNO>
	<brief_summary>The DEBATER study design determine superiority abciximab abciximab determine superiority drug elute stent bare metal stent patient acute myocardial infarction undergo percutaneous coronary intervention .</brief_summary>
	<brief_title>Comparison Drug Eluting Bare Metal Stents With Without Abciximab ST Elevation Myocardial Infarction</brief_title>
	<detailed_description>In patient acute myocardial infarction primary PCI without prior thrombolytic therapy , treatment choice . The recommendation routine stenting PCI base 4 study demonstrate usefulness bare metal stent patient STEMI . However recommendation extrapolate ( yet ) use drug eluting stent . Although DES use widely unstable angina acute myocardial infarction , date evidence-based recommendation support routine use DES STEMI . GPI study extensively patient non-STsegment elevation myocardial infarction ( NSTEMI ) plan perform PCI . In STEMI tirofiban eptifibatide less well investigate , abciximab recommend primary PCI , long term benefit require investigation . In PCI randomize controlled clinical trial ( RCT 's ) abciximab consistently show significant reduction rate myocardial infarction need urgent revascularization . Abciximab evaluate 5 RCT 's association primary PCI . The pooled analysis clinical outcome 30 day , demonstrate significant reduction death , re- infarction target vessel revascularization ( TVR ) , mainly due reduction repeat intervention . The long-term benefit require investigation . The DEBATER trial design answer question need abciximab use DES primary PCI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Abciximab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin Fab Fragments</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>STEMI â‰¤ 12 hour ( STEMI equivalent ) . No contra indication primary PCI . No contra indication abciximab . Informed consent patient . Contra indication primary PCI : History peripheral/coronary artery disease inaccessible angiography PCI . Contra indication GPI : Ongoing bleeding , bleed diathesis , cerebrovascular accident &lt; 6 month , major surgery/trauma &lt; 6 month , platelet count &lt; 100.000 mm3 , intracranial arteriovenous malformation neoplasm , malignant hypertension , INR &gt; 1.5 , severe hepatic dysfunction Contra indication clopidogrel : Severe liver dysfunction , pathological bleeding disorder peptic ulcer intracranial bleeding . Thrombolytic therapy &lt; 24 hour . Therapy GPI &lt; 24 hour . Anticoagulation therapy . Co morbid condition predictable fatal outcome short run . No informed consent : refusal , coma , artificial respiration , impaired mentation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>STEMI</keyword>
	<keyword>DES</keyword>
	<keyword>BMS</keyword>
	<keyword>abciximab</keyword>
</DOC>